Eli Lilly and Company has announced a significant research collaboration and licensing agreement with Ascidian Therapeutics, a pioneering biotechnology firm…
Read More
Beyond PD-1: The drugs reshaping cancer treatment at ASCO 2026
The biotechnology sector, a critical engine of medical innovation, is experiencing a robust resurgence, marking a significant turnaround from recent…
Read More
European Commission Approves AbbVie’s Aquipta (atogepant) for Acute Migraine Treatment
AbbVie has secured a significant regulatory endorsement from the European Commission (EC) for Aquipta (atogepant), marking a pivotal expansion of…
Read More
ASCO 2026 Delivers Promising Advances and Crucial Data in Blood Cancer Treatment
The 2026 American Society of Clinical Oncology (ASCO) conference, a cornerstone event for oncological advancements, has concluded, leaving a significant…
Read More
Brinsupri Poised to Redefine Bronchiectasis Treatment Standards Following Robust ATS 2026 Showcase
The landscape of non-cystic fibrosis bronchiectasis (NCFB) treatment is undergoing a significant transformation with the emergence of Brinsupri (brensocatib), a…
Read More
Breakthrough Discovery of Fam102a Protein as Key Regulator in Bone Remodeling Offers New Pathways for Osteoporosis Treatment
In a landmark study published in Nature Communications on January 2, 2025, a multidisciplinary team of researchers led by Professor…
Read More
Singaporean Scientists Unveil Revolutionary Spinach-Derived Photosynthetic Treatment for Chronic Dry Eye Disease
The landscape of ophthalmological treatments is on the cusp of a profound transformation, spearheaded by groundbreaking research from the National…
Read More
Indiana University School of Medicine Researchers Revolutionize Bone Marrow Imaging with Breakthrough Multiplex Technique to Advance Disease Treatment
The Indiana University School of Medicine has announced a significant leap forward in regenerative medicine and oncology through the development…
Read More
Duke-NUS Researchers Identify DEAF1 Protein as Key Regulator in Muscle Regeneration and Treatment for Sarcopenia and Cachexia
In an era defined by a rapidly aging global population, the medical community is facing an unprecedented rise in age-related…
Read More
Beyond PD-1: The drugs reshaping cancer treatment at ASCO 2026
The biotechnology sector is experiencing a significant resurgence, marked by a robust recovery in public markets and an explosion in…
Read More
